Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 4 , Pages 547-560, December 2006

The genetics of ACTH resistance syndromes

  • Louise A. Metherell, PhD (Senior Postdoctoral Fellow in Professor Clark's lab)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 20 7882 6241; Fax: +44 20 7882 6197.
  • Li F. Chan, MRCPCH (Clinical Research Training Fellow in Professor Clark's lab)

Centre for Endocrinology, William Harvey Research Institute, Queen Mary's School of Medicine and Dentistry at Barts & The London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK

Inherited adrenocorticotropin (ACTH) resistance diseases are rare and include triple A syndrome and familial glucocorticoid deficiency (FGD). These conditions show genetic heterogeneity, i.e., the identical clinical phenotype may result from defects in more than one gene. Clinically, FGD is characterized only by ACTH resistance, while the triple A syndrome exhibits a variety of additional clinical features. FGD is caused by mutations in the ACTH receptor (melanocortin 2 receptor, MC2R) and the recently identified melanocortin 2 receptor accessory protein (MRAP) genes. In addition, linkage to a locus on chromosome 8 has been demonstrated. The identification of further genes in ACTH resistance syndromes may reveal novel aspects of MC2R signalling and trafficking. This review will summarize the clinical, biochemical and genetic aspects of these rare but informative diseases.

Key words: melanocortin 2 receptor, ACTH resistance, melanocortin 2 receptor accessory protein, familial glucocorticoid deficiency

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(06)00073-X

doi:10.1016/j.beem.2006.09.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 4 , Pages 547-560, December 2006